03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Kyprolis : | |
Type | Medicine Authorised |
Originator | B |
Agent | Mersaco |
Distributor | Mersaco |
Laboratory | Amgen |
Responsible Party | Onyx Pharmaceuticals Inc |
Origin | U.S.A. |
Manufacturer | Amgen Technology |
Origin | Ireland |
ATC | L01XX45 |
Kyprolis :
Kyprolis :
Kyprolis :
Kyprolis :
Kyprolis :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Kyprolis :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Very Common |
Acute respiratory distress syndrome | Uncommon |
Acute respiratory failure | Uncommon |
ALT increased | Common |
Anaemia | Very Common |
Anxiety | Common |
Arthralgia (Pain joint) (Joint ache) | Very Common |
AST increased | Common |
Asthenia | Very Common |
Atrial fibrillation | Common |
Back pain | Very Common |
Blood creatinine increased | Very Common |
Blood uric acid increased | Common |
Bone pain | Common |
Bronchitis | Common |
C-reactive protein increased | Common |
Cardiac arrest | Uncommon |
Cardiac failure | Common |
Cataract | Common |
Cerebrovascular accident | Uncommon |
Chest pain | Common |
Chills | Common |
Cholestasis | Uncommon |
Constipation | Very Common |
Cough | Very Common |
Creatinine renal clearance decreased | Common |
Decreased appetite | Very Common |
Deep vein thrombosis | Common |
Dehydration | Common |
Diarrhoea (Diarrhea) | Very Common |
Dizziness | Very Common |
Drug hypersensitivity | Uncommon |
Dyspepsia | Common |
Dysphonia | Common |
Dyspnoea (dyspnea) | Very Common |
Ejection fraction decreased | Uncommon |
Epistaxis (Nasal bleeding) | Common |
Erythema | Common |
Fatigue | Very Common |
Febrile neutropenia (Neutropenic fever) | Common |
Flushing | Common |
Gamma-GT increased | Common |
Gastroduodenal haemorrhage | Uncommon |
Gastrointestinal perforation | Uncommon |
Haemolytic uraemic syndrome (HUS) | Uncommon |
Haemorrhage | Uncommon |
Haemorrhage intracranial | Uncommon |
Headache | Very Common |
Hepatic failure (Hepatic insufficiency) (Liver failure) | Uncommon |
Hyperbilirubinaemia | Common |
Hypercalcaemia | Common |
Hyperglycaemia | Very Common |
Hyperhidrosis | Common |
Hyperkalaemia | Common |
Hypertension | Very Common |
Hypertensive crisis | Uncommon |
Hypertensive emergency | Rare |
Hyperuricaemia | Common |
Hypoalbuminaemia | Common |
Hypocalcaemia | Common |
Hypoesthesia | Common |
Hypokalaemia | Very Common |
Hypomagnesaemia | Common |
Hyponatraemia (Hyponatremia) | Common |
Hypophosphataemia | Common |
Hypotension | Common |
Influenza | Common |
Infusion related reaction | Very Common |
Infusion site reactions | Common |
Insomnia | Very Common |
Interstitial lung disease | Uncommon |
Leucopenia (Leukopenia) | Common |
Lung infection | Uncommon |
Lymphopenia | Very Common |
Multi-organ failure | Uncommon |
Muscle spasms | Very Common |
Muscle weakness | Common |
Musculoskeletal chest pain | Common |
Musculoskeletal pain | Common |
Myalgia | Common |
Myocardial infarction | Uncommon |
Myocardial ischaemia | Uncommon |
Nasopharyngitis | Very Common |
Nausea | Very Common |
Neuropathy peripheral | Very Common |
Neutropenia | Very Common |
Oedema peripheral | Very Common |
Oropharyngeal pain | Common |
Pain | Common |
Pain in extremity (Pain in limb) | Very Common |
Palpitations | Common |
Paraesthesia (paresthesia) | Common |
Pericardial effusion | Uncommon |
Pericarditis | Uncommon |
Pneumonia | Very Common |
Pneumonitis | Uncommon |
Posterior reversible leukoencephalopathy syndrome (PRES) | Rare |
Pruritus | Common |
Pulmonary embolism | Common |
Pulmonary haemorrhage | Uncommon |
Pulmonary hypertension | Common |
Pulmonary oedema | Common |
Pyrexia | Very Common |
Renal failure | Common |
Renal failure acute (Acute renal insufficiency) (Kidney failure acute) (Renal insufficiency acute) | Common |
Renal impairment | Common |
Respiratory tract infection | Very Common |
Rhinitis | Common |
Sepsis (Systemic infection) (Sepsis state) | Common |
Skin rash | Common |
Tachycardia | Common |
Thrombocytopenia (Thrombopenia) | Very Common |
Thrombotic microangiopathy | Rare |
Thrombotic thrombocytopenic purpura (TTP) | Rare |
Toothache | Common |
Tumour lysis syndrome | Uncommon |
Urinary tract infection | Common |
Viral infection | Common |
Vision blurred | Common |
Vomiting | Very Common |
Wheezing | Common |
Kyprolis :
NB : Products With Same Indication |
Different Units By MoH Code
Kyprolis MoH 8499 :
Form | Powder for solution for injection |
Packaging | Vial (Type I Glass) |
Package Size | Box of 1 |
Strength | 60mg |
Storage Condition | 2-8°C protect from light |
Public Price | 1813283 L.L. |
Stratum | E2 |
NSSF | ✔ |
Quarantine | ✔ |
Reg. Number | 150015/1 |
Submission date | 01/01/2015 |
Registration Year | 2016 |
Price Comparison
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
Note
You have to register to view this info
Drop File